PATENT CLAIM ANALYSIS

Application Number: 15902886
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "013700"]

Abstract:
The present disclosure provides unit dose formulations and methods to reduce, stop or prevent bleeding in a patient undergoing anticoagulant therapy with a factor Xa inhibitor. The methods entail at least partial neutralization of the factor Xa inhibitors The unit dose formulations and methods of the present disclosure can be effective even after actual bleeding has initiated.

Claim (Index 4):
The unit dose formulation of  claim 1 , having from about 35 milligrams to about 60 milligrams of the polypeptide.

Metadata:
- Claim Count in Document: 84.0
- Percentile: 88.0
- Lexical Diversity: 1.39535
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12836536', '13414499', '13889014', '12239651', '15435086']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8775875969742701
- 35 USC 102 Novelty (BERT): 0.5741253991300924
- Combined Prediction Score: 0.8472413771898524
- Mean Citation Score: 601.027832
- Max Citation Score: 613.67346
- Similarity Product: 355.5830709888124

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test